Literature DB >> 16990275

Cysteine accessibility in the hydrophilic cleft of human organic cation transporter 2.

Ryan M Pelis1, Xiaohong Zhang, Yodying Dangprapai, Stephen H Wright.   

Abstract

Organic cation transporters (OCTs) are involved in the renal elimination of many cationic drugs and toxins. A hypothetical three-dimensional structure of OCT2 based on a homology model that used the Escherichia coli glycerol 3-phosphate transporter as a template has been described (Zhang, X., Shirahatti, N. V., Mahadevan, D., and Wright, S. H. (2005) J. Biol. Chem. 280, 34813-34822). To further define OCT structure, the accessibility to hydrophilic thiol-reactive reagents of the 13 cysteine residues contained in the human ortholog of OCT2 was examined. Maleimide-PEO2-biotin precipitated (surface biotinylation followed by Western blotting) and reduced tetraethylammonium transport by OCT2 expressed in Chinese hamster ovary cells, effects that were largely reversed by co-exposure to substrates and transport inhibitors, suggesting interaction with cysteines that are near to or part of a substrate-binding surface. Cysteines at amino acid position 437, 451, 470, and 474 were identified from the model as being located in transmembrane helices that participate in forming the hydrophilic cleft, the proposed region of substrate-protein interaction. To determine which residues are exposed to the solvent, a mutant with all four of these cysteines converted to alanine, along with four variants of this mutant each with an individual cysteine restored, were created. Maleimide-PEO2-biotin was only effective at precipitating and reducing transport by wild-type OCT2 and the mutant with cysteine 474 restored. Additionally, the smaller thiol-reactive reagent, methanethiosulfonate ethylsulfonate, reduced transport by wild-type OCT2 and the mutant with cysteine 474 restored. These data demonstrate that cysteine 474 of OCT2 is exposed to the aqueous milieu of the cleft and contributes to forming a pathway for organic cation transport.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16990275     DOI: 10.1074/jbc.M606561200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  15 in total

Review 1.  Drug uptake systems in liver and kidney: a historic perspective.

Authors:  B Hagenbuch
Journal:  Clin Pharmacol Ther       Date:  2009-11-18       Impact factor: 6.875

2.  The cysteines of the extracellular loop are crucial for trafficking of human organic cation transporter 2 to the plasma membrane and are involved in oligomerization.

Authors:  Sabine Brast; Alexander Grabner; Sonja Sucic; Harald H Sitte; Edwin Hermann; Hermann Pavenstädt; Eberhard Schlatter; Giuliano Ciarimboli
Journal:  FASEB J       Date:  2011-11-15       Impact factor: 5.191

3.  Role of a Hydrophobic Pocket in Polyamine Interactions with the Polyspecific Organic Cation Transporter OCT3.

Authors:  Dan C Li; Colin G Nichols; Monica Sala-Rabanal
Journal:  J Biol Chem       Date:  2015-09-24       Impact factor: 5.157

4.  Differences in the substrate binding regions of renal organic anion transporters 1 (OAT1) and 3 (OAT3).

Authors:  Bethzaida Astorga; Theresa M Wunz; Mark Morales; Stephen H Wright; Ryan M Pelis
Journal:  Am J Physiol Renal Physiol       Date:  2011-05-04

5.  Substrate-dependent ligand inhibition of the human organic cation transporter OCT2.

Authors:  Mathew Belzer; Mark Morales; Bhumasamudram Jagadish; Eugene A Mash; Stephen H Wright
Journal:  J Pharmacol Exp Ther       Date:  2013-05-24       Impact factor: 4.030

6.  Residues gating the periplasmic pathway of LacY.

Authors:  Yonggang Zhou; Yiling Nie; H Ronald Kaback
Journal:  J Mol Biol       Date:  2009-09-23       Impact factor: 5.469

7.  The multidrug transporter MATE1 sequesters OCs within an intracellular compartment that has no influence on OC secretion in renal proximal tubules.

Authors:  L J Martínez-Guerrero; K K Evans; W H Dantzler; S H Wright
Journal:  Am J Physiol Renal Physiol       Date:  2015-11-04

8.  Functional significance of conserved cysteines in the human organic cation transporter 2.

Authors:  Ryan M Pelis; Yodying Dangprapai; Yaofeng Cheng; Xiaohong Zhang; Jennifer Terpstra; Stephen H Wright
Journal:  Am J Physiol Renal Physiol       Date:  2012-05-09

9.  Kinetic basis of metformin-MPP interactions with organic cation transporter OCT2.

Authors:  Philip J Sandoval; Mark Morales; Timothy W Secomb; Stephen H Wright
Journal:  Am J Physiol Renal Physiol       Date:  2019-07-17

Review 10.  Polyspecific organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications.

Authors:  Hermann Koepsell; Katrin Lips; Christopher Volk
Journal:  Pharm Res       Date:  2007-05-01       Impact factor: 4.580

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.